A Study of WJ05129 in Advanced Malignant Solid Tumors
Stopped The sponsor terminated the study on the basis of the current data and the company's research and development strategy
Conditions
- Locally Advanced or Metastatic Malignant Solid Tumors
Interventions
- DRUG: WJ05129
- DRUG: Paclitaxel injection
Sponsor
Suzhou Junjing BioSciences Co., Ltd.
Collaborators